Ryan N. Henderson

Array ( [id] => 5585011 [patent_doc_number] => 20090104213 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'Vaccine for House Dust Mite Allergen Using Naked DNA' [patent_app_type] => utility [patent_app_number] => 12/204425 [patent_app_country] => US [patent_app_date] => 2008-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 13740 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20090104213.pdf [firstpage_image] =>[orig_patent_app_number] => 12204425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5441390 [patent_doc_number] => 20090093029 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'METHOD FOR PRODUCING L-AMINO ACID' [patent_app_type] => utility [patent_app_number] => 12/202484 [patent_app_country] => US [patent_app_date] => 2008-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12718 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20090093029.pdf [firstpage_image] =>[orig_patent_app_number] => 12202484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6621086 [patent_doc_number] => 20100050276 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'Transgenic non-human animal models of apoptosis-mediated conditions' [patent_app_type] => utility [patent_app_number] => 12/229438 [patent_app_country] => US [patent_app_date] => 2008-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 20265 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0050/20100050276.pdf [firstpage_image] =>[orig_patent_app_number] => 12229438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6254366 [patent_doc_number] => 20100138946 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'Transgenic chickens with an inactivated endogenous gene locus' [patent_app_type] => utility [patent_app_number] => 12/192020 [patent_app_country] => US [patent_app_date] => 2008-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 28338 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20100138946.pdf [firstpage_image] =>[orig_patent_app_number] => 12192020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5379321 [patent_doc_number] => 20090191160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'Methods of producing pluripotent stem-like cells' [patent_app_type] => utility [patent_app_number] => 12/228205 [patent_app_country] => US [patent_app_date] => 2008-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14767 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20090191160.pdf [firstpage_image] =>[orig_patent_app_number] => 12228205 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6009084 [patent_doc_number] => 20110061116 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'Animal Model of Synovial Sarcoma' [patent_app_type] => utility [patent_app_number] => 12/666268 [patent_app_country] => US [patent_app_date] => 2008-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 33374 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20110061116.pdf [firstpage_image] =>[orig_patent_app_number] => 12666268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5409534 [patent_doc_number] => 20090123432 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'Novel population of hepatocytes derived via definitive endoderm (DE-hep) from human blastocysts derived stem cells' [patent_app_type] => utility [patent_app_number] => 12/219298 [patent_app_country] => US [patent_app_date] => 2008-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 52 [patent_no_of_words] => 32630 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20090123432.pdf [firstpage_image] =>[orig_patent_app_number] => 12219298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5440912 [patent_doc_number] => 20090092551 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'Increasing lifespan by modulation of pha-4' [patent_app_type] => utility [patent_app_number] => 12/218976 [patent_app_country] => US [patent_app_date] => 2008-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 30332 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20090092551.pdf [firstpage_image] =>[orig_patent_app_number] => 12218976 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5309718 [patent_doc_number] => 20090016999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => 'Embryonic cell compositions for wound treatment' [patent_app_type] => utility [patent_app_number] => 12/216971 [patent_app_country] => US [patent_app_date] => 2008-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5322 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20090016999.pdf [firstpage_image] =>[orig_patent_app_number] => 12216971 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5391152 [patent_doc_number] => 20090208465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'METHOD OF TREATING NEURAL DEFECTS' [patent_app_type] => utility [patent_app_number] => 12/164827 [patent_app_country] => US [patent_app_date] => 2008-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3610 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20090208465.pdf [firstpage_image] =>[orig_patent_app_number] => 12164827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5363230 [patent_doc_number] => 20090038024 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-05 [patent_title] => 'CAP/SORBS1 AND DIABETES' [patent_app_type] => utility [patent_app_number] => 12/141782 [patent_app_country] => US [patent_app_date] => 2008-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 24148 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20090038024.pdf [firstpage_image] =>[orig_patent_app_number] => 12141782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6282085 [patent_doc_number] => 20100257620 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'TRANSGENIC ANIMALS FOR ASSESSING DRUG METABOLSIM AND TOXICITY' [patent_app_type] => utility [patent_app_number] => 12/602723 [patent_app_country] => US [patent_app_date] => 2008-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 135 [patent_figures_cnt] => 135 [patent_no_of_words] => 45267 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12602723 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6589427 [patent_doc_number] => 20100235929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'Compositions and Methods for Producing Antibodies Having Human Idiotypes in Transgenic Birds' [patent_app_type] => utility [patent_app_number] => 12/602480 [patent_app_country] => US [patent_app_date] => 2008-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8462 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20100235929.pdf [firstpage_image] =>[orig_patent_app_number] => 12602480 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5284459 [patent_doc_number] => 20090098134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITING ENDOGENOUS IMMUNOGLOBULIN GENES AND PRODUCING TRANSGENIC HUMAN IDIOTYPE ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/130818 [patent_app_country] => US [patent_app_date] => 2008-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14563 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20090098134.pdf [firstpage_image] =>[orig_patent_app_number] => 12130818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6635830 [patent_doc_number] => 20100226912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'RECOMBINANT PROTEIN PRODUCTION IN AVIAN EBx® CELLS' [patent_app_type] => utility [patent_app_number] => 12/601178 [patent_app_country] => US [patent_app_date] => 2008-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 29485 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20100226912.pdf [firstpage_image] =>[orig_patent_app_number] => 12601178 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6052892 [patent_doc_number] => 20110209231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'TREATMENT AND PREVENTION OF INFLUENZA' [patent_app_type] => utility [patent_app_number] => 12/451540 [patent_app_country] => US [patent_app_date] => 2008-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17693 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20110209231.pdf [firstpage_image] =>[orig_patent_app_number] => 12451540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4839347 [patent_doc_number] => 20080279832 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'OSTEOGENIC DIFFERENTIATION OF PREOSTEOBLASTIC CELLS' [patent_app_type] => utility [patent_app_number] => 12/119288 [patent_app_country] => US [patent_app_date] => 2008-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9761 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20080279832.pdf [firstpage_image] =>[orig_patent_app_number] => 12119288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9843310 [patent_doc_number] => 08945219 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2015-02-03 [patent_title] => 'System for and method of introducing additives to biological materials using supercritical fluids' [patent_app_type] => utility [patent_app_number] => 12/151841 [patent_app_country] => US [patent_app_date] => 2008-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4428 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12151841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4713296 [patent_doc_number] => 20080301822 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'Role of alpha1-adrenergic receptors' [patent_app_type] => utility [patent_app_number] => 12/151594 [patent_app_country] => US [patent_app_date] => 2008-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 25724 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0301/20080301822.pdf [firstpage_image] =>[orig_patent_app_number] => 12151594 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4676270 [patent_doc_number] => 20080213900 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Engineered Protein Kinases Which Can Utilize Modified Nucleotide Triphosphate Substrates' [patent_app_type] => utility [patent_app_number] => 12/113647 [patent_app_country] => US [patent_app_date] => 2008-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 28386 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213900.pdf [firstpage_image] =>[orig_patent_app_number] => 12113647 [rel_patent_id] =>[rel_patent_doc_number] =>)